LUCID DIAGNOSTICS INC (LUCD) Fundamental Analysis & Valuation
NASDAQ:LUCD • US54948X1090
Current stock price
1.15 USD
-0.04 (-3.36%)
At close:
1.16 USD
+0.01 (+0.87%)
After Hours:
This LUCD fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.
1. LUCD Profitability Analysis
1.1 Basic Checks
- In the past year LUCD has reported negative net income.
- In the past year LUCD has reported a negative cash flow from operations.
- LUCD had negative earnings in each of the past 5 years.
- LUCD had a negative operating cash flow in each of the past 5 years.
1.2 Ratios
- LUCD's Return On Assets of -123.77% is on the low side compared to the rest of the industry. LUCD is outperformed by 84.13% of its industry peers.
- With a Return On Equity value of -254.86%, LUCD is not doing good in the industry: 77.25% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -123.77% | ||
| ROE | -254.86% | ||
| ROIC | N/A |
ROA(3y)-179.51%
ROA(5y)-192.84%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- The Profit Margin and Operating Margin and Gross Margin are not available for LUCD so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | N/A |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
2. LUCD Health Analysis
2.1 Basic Checks
- LUCD does not have a ROIC to compare to the WACC, probably because it is not profitable.
- LUCD has more shares outstanding than it did 1 year ago.
- The number of shares outstanding for LUCD has been increased compared to 5 years ago.
- The debt/assets ratio for LUCD has been reduced compared to a year ago.
2.2 Solvency
- Based on the Altman-Z score of -5.74, we must say that LUCD is in the distress zone and has some risk of bankruptcy.
- The Altman-Z score of LUCD (-5.74) is worse than 72.49% of its industry peers.
- LUCD has a Debt/Equity ratio of 0.86. This is a neutral value indicating LUCD is somewhat dependend on debt financing.
- The Debt to Equity ratio of LUCD (0.86) is worse than 72.49% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.86 | ||
| Debt/FCF | N/A | ||
| Altman-Z | -5.74 |
ROIC/WACCN/A
WACC10.38%
2.3 Liquidity
- A Current Ratio of 1.90 indicates that LUCD should not have too much problems paying its short term obligations.
- The Current ratio of LUCD (1.90) is worse than 65.08% of its industry peers.
- LUCD has a Quick Ratio of 1.88. This is a normal value and indicates that LUCD is financially healthy and should not expect problems in meeting its short term obligations.
- LUCD has a Quick ratio (1.88) which is in line with its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.9 | ||
| Quick Ratio | 1.88 |
3. LUCD Growth Analysis
3.1 Past
- The Earnings Per Share has grown by an impressive 22.12% over the past year.
- The Revenue has been growing slightly by 5.01% in the past year.
- LUCD shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 105.61% yearly.
EPS 1Y (TTM)22.12%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%60%
Revenue 1Y (TTM)5.01%
Revenue growth 3Y105.61%
Revenue growth 5YN/A
Sales Q2Q%3.33%
3.2 Future
- Based on estimates for the next years, LUCD will show a quite strong growth in Earnings Per Share. The EPS will grow by 11.96% on average per year.
- LUCD is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 75.37% yearly.
EPS Next Y34.33%
EPS Next 2Y29.31%
EPS Next 3Y21.51%
EPS Next 5Y11.96%
Revenue Next Year-0.06%
Revenue Next 2Y58.79%
Revenue Next 3Y80.67%
Revenue Next 5Y75.37%
3.3 Evolution
- Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
4. LUCD Valuation Analysis
4.1 Price/Earnings Ratio
- LUCD reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
- Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for LUCD. No positive earnings are expected for the next year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
- A more expensive valuation may be justified as LUCD's earnings are expected to grow with 21.51% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y29.31%
EPS Next 3Y21.51%
5. LUCD Dividend Analysis
5.1 Amount
- No dividends for LUCD!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
LUCD Fundamentals: All Metrics, Ratios and Statistics
1.15
-0.04 (-3.36%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)03-23 2026-03-23/amc
Earnings (Next)05-12 2026-05-12/bmo
Inst Owners25.56%
Inst Owner Change-10.29%
Ins Owners9.08%
Ins Owner Change10.52%
Market Cap150.56M
Revenue(TTM)4.40M
Net Income(TTM)-65.84M
Analysts83.33
Price Target3.87 (236.52%)
Short Float %8.39%
Short Ratio4.58
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)23.11%
Min EPS beat(2)11.04%
Max EPS beat(2)35.18%
EPS beat(4)3
Avg EPS beat(4)-42.23%
Min EPS beat(4)-222.25%
Max EPS beat(4)35.18%
EPS beat(8)4
Avg EPS beat(8)-28.03%
EPS beat(12)6
Avg EPS beat(12)-15.73%
EPS beat(16)7
Avg EPS beat(16)-15.95%
Revenue beat(2)0
Avg Revenue beat(2)-6.34%
Min Revenue beat(2)-12.5%
Max Revenue beat(2)-0.17%
Revenue beat(4)0
Avg Revenue beat(4)-16.73%
Min Revenue beat(4)-36.75%
Max Revenue beat(4)-0.17%
Revenue beat(8)1
Avg Revenue beat(8)-12.2%
Revenue beat(12)2
Avg Revenue beat(12)-11.77%
Revenue beat(16)2
Avg Revenue beat(16)-24.93%
PT rev (1m)0%
PT rev (3m)1.11%
EPS NQ rev (1m)1.96%
EPS NQ rev (3m)3.85%
EPS NY rev (1m)0%
EPS NY rev (3m)1.09%
Revenue NQ rev (1m)-2.05%
Revenue NQ rev (3m)-6.66%
Revenue NY rev (1m)-0.6%
Revenue NY rev (3m)-4.69%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 34.23 | ||
| P/FCF | N/A | ||
| P/OCF | N/A | ||
| P/B | 5.83 | ||
| P/tB | 5.92 | ||
| EV/EBITDA | N/A |
EPS(TTM)-0.88
EYN/A
EPS(NY)-0.35
Fwd EYN/A
FCF(TTM)-0.34
FCFYN/A
OCF(TTM)-0.33
OCFYN/A
SpS0.03
BVpS0.2
TBVpS0.19
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -123.77% | ||
| ROE | -254.86% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | N/A | ||
| FCFM | N/A |
ROA(3y)-179.51%
ROA(5y)-192.84%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0.08
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.86 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | 45.76% | ||
| Cap/Sales | 9.21% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.9 | ||
| Quick Ratio | 1.88 | ||
| Altman-Z | -5.74 |
F-Score4
WACC10.38%
ROIC/WACCN/A
Cap/Depr(3y)37.04%
Cap/Depr(5y)N/A
Cap/Sales(3y)87.81%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)22.12%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%60%
EPS Next Y34.33%
EPS Next 2Y29.31%
EPS Next 3Y21.51%
EPS Next 5Y11.96%
Revenue 1Y (TTM)5.01%
Revenue growth 3Y105.61%
Revenue growth 5YN/A
Sales Q2Q%3.33%
Revenue Next Year-0.06%
Revenue Next 2Y58.79%
Revenue Next 3Y80.67%
Revenue Next 5Y75.37%
EBIT growth 1Y-6.37%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-10.07%
EBIT Next 3Y6.31%
EBIT Next 5Y4.51%
FCF growth 1Y-61.55%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-61.54%
OCF growth 3YN/A
OCF growth 5YN/A
LUCID DIAGNOSTICS INC / LUCD Fundamental Analysis FAQ
What is the fundamental rating for LUCD stock?
ChartMill assigns a fundamental rating of 2 / 10 to LUCD.
Can you provide the valuation status for LUCID DIAGNOSTICS INC?
ChartMill assigns a valuation rating of 1 / 10 to LUCID DIAGNOSTICS INC (LUCD). This can be considered as Overvalued.
What is the profitability of LUCD stock?
LUCID DIAGNOSTICS INC (LUCD) has a profitability rating of 0 / 10.
What is the expected EPS growth for LUCID DIAGNOSTICS INC (LUCD) stock?
The Earnings per Share (EPS) of LUCID DIAGNOSTICS INC (LUCD) is expected to grow by 34.33% in the next year.